8-K

                        SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C. 20549

                                   FORM 8-K

                                CURRENT REPORT

                       PURSUANT TO SECTION 13 OR 15 (d)
                    OF THE SECURITIES EXCHANGE ACT OF 1934


     DATE OF REPORT (Date of earliest event reported):  November 19, 1999

                      AMERICAN HOME PRODUCTS CORPORATION
            (Exact name of registrant as specified in its charter)


          Delaware                  1-1225                  13-2526821
(State or other jurisdiction    (Commission FilE          (IRS Employer
of incorporation)                    Number)            Identification No.)




Five Giralda Farms, Madison, New Jersey                       07940
(Address of Principal Executive Offices)                   (Zip Code)



       Registrant's telephone number, including area code:  973-660-5000



Item 5.  Other Events

          On November 19, 1999, American Home Products Corporation ("AHP")
issued a press release announcing that the Delaware Chancery Court had
adopted the schedule proposed by Warner-Lambert Company ("Warner-Lambert")
and AHP and set a preliminary hearing for January 24, 2000 with respect to
Pfizer Inc.'s amended complaint challenging certain aspects of the Agreement
and Plan of Merger, dated as of November 3, 1999, among AHP, Wolverine Sub
Corp., a Delaware corporation and wholly owned subsidiary of AHP, and Warner-
Lambert.  A copy of the press release is filed as Exhibit 99.1 hereto and is
incorporated herein by reference.


Item 7.    Financial Statements and Exhibits

     (c)  Exhibits

          (99.1)    Press Release, dated November 19, 1999






























                                      -2-



          Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.


                          AMERICAN HOME PRODUCTS CORPORATION



                          By: /s/ Gerald A. Jibilian
                              --------------------------
                              Name:  Gerald A. Jibilian
                              Title: Vice President





Dated:  November 22, 1999






























                                      -3-



                                 EXHIBIT INDEX



                 (99.1)   Press Release, dated November 19, 1999











































                                      -4-

EX-99.1

                       AMERICAN HOME PRODUCTS CORPORATION
        FIVE GIRALDA FARMS, MADISON, NEW JERSEY  07940, (973) 660-5000


                                                             EXECUTIVE OFFICES

FOR IMMEDIATE RELEASE
Media Contact:                                Investor Contact:
Lowell Weiner                                 Thomas Cavanagh
(973) 660-5013                                (973) 660-5706


             AMERICAN HOME PRODUCTS STATES THAT DELAWARE COURT OF
                  CHANCERY SETS HEARING FOR JANUARY 24, 2000



     Madison, N.J., November 19, 1999 -- American Home Products Corporation

(NYSE: AHP) today stated that the Delaware Chancery Court has adopted the

schedule proposed by Warner-Lambert and American Home Products and set a

preliminary hearing for January 24, 2000 with respect to Pfizer Inc's

amended complaint challenging certain aspects of the merger agreement between

Warner-Lambert and American Home Produces announced on November 4, 1999

     American Home Products stated, "We look forward to presenting our case

in the Delaware Court of Chancery and are confident that our arguments will

prevail.  We remain committed to our announced merger of equals transaction

which we believe is strategically and financially compelling for our

shareholders, and which will create enormous near and long-term value for the

shareholders of both companies."

     American Home Products Corporation is one of the world's largest

research-based pharmaceutical and health care product companies.  It is a

leader in the discovery, development, manufacturing, and marketing of

prescription drugs and over-the-counter medications.  It is also a global



leader in vaccines, biotechnology, agricultural products, and animal health

care.  In 1999, its revenues are expected to approach $14 billion and the

company will invest $1.8 billion in research and development.  It employs

52,000 people worldwide.

     Statements made in this press release that state "we will," "we expect,"
or otherwise state the companies' predictions for the future are forward-
looking statements.   Actual results might differ materially from those
projected in the forward-looking statements.  Additional information
concerning factors that could cause actual results to materially differ from
those in the forward-looking statements is contained in the Company's annual
report on Form 10K for the year ended December 31, 1998 filed with the U.S.
Securities and Exchange Commission.  For a copy of these filings, call the
media contacts listed on this press release.



                                 #####



























                                      -2-